Ligand Pharmaceuticals In shares owned by Rice Hall James & Associates
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Rice Hall James & Associates
from 13F filings
Historical chart of Rice Hall James & Associates investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Rice Hall James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Rice Hall James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $21M | 280k | 73.10 |
| 2023-12-31 | $20M | 276k | 71.42 |
| 2023-09-30 | $17M | 283k | 59.92 |
| 2023-06-30 | $21M | 288k | 72.10 |
| 2023-03-31 | $21M | 288k | 73.56 |
| 2022-12-31 | $19M | 286k | 66.80 |
| 2022-09-30 | $26M | 297k | 86.11 |
| 2022-06-30 | $30M | 335k | 89.22 |
| 2022-03-31 | $39M | 345k | 112.49 |
| 2021-12-31 | $54M | 348k | 154.46 |
| 2021-09-30 | $52M | 374k | 139.32 |
| 2021-06-30 | $50M | 379k | 131.19 |
| 2021-03-31 | $66M | 430k | 152.45 |
| 2020-12-31 | $50M | 504k | 99.45 |
| 2020-09-30 | $37M | 387k | 95.32 |
| 2020-06-30 | $37M | 332k | 111.85 |
| 2020-03-31 | $25M | 338k | 72.72 |
| 2019-12-31 | $32M | 303k | 104.29 |
| 2019-09-30 | $31M | 316k | 99.54 |
| 2019-06-30 | $37M | 322k | 114.15 |
| 2019-03-31 | $43M | 342k | 125.71 |
| 2018-12-31 | $37M | 275k | 135.70 |
| 2018-09-30 | $53M | 191k | 274.49 |
| 2018-06-30 | $55M | 267k | 207.17 |
| 2018-03-31 | $50M | 305k | 165.16 |
| 2017-12-31 | $42M | 307k | 136.93 |
| 2017-09-30 | $37M | 268k | 136.15 |
| 2017-06-30 | $34M | 279k | 121.40 |
| 2017-03-31 | $23M | 220k | 105.84 |
| 2016-12-31 | $21M | 211k | 101.61 |
| 2016-09-30 | $21M | 209k | 102.06 |
| 2016-06-30 | $22M | 186k | 119.27 |
| 2016-03-31 | $20M | 184k | 107.09 |
| 2015-12-31 | $20M | 180k | 108.42 |
| 2015-09-30 | $8.9M | 104k | 85.65 |
| 2015-06-30 | $9.6M | 95k | 100.90 |
| 2015-03-31 | $8.0M | 104k | 77.11 |
More positions owned by Rice Hall James & Associates
View all positions for Rice Hall James & Associates